ArticleCureus2025
Enhanced Recovery After Surgery (ERAS®) Protocol in Colorectal Resections: A Prospective Observational Study of Implementation and Outcomes at a Tertiary Referral Center.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to evaluate the implementation of the Enhanced Recovery After Surgery (ERAS®) protocol in patients undergoing colorectal cancer resections at a tertiary care center in India, and to assess whether protocol compliance influences the length of hospital stay and postoperative complications. MATERIALS AND
methodsWe conducted a prospective observational study of 50 consecutive patients undergoing colorectal cancer resection surgery at Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, between May 2024 and April 2025. A 16-item ERAS® protocol was implemented, and compliance was measured. Primary outcomes included the length of hospital stay, postoperative complications (classified according to the Clavien-Dindo classification), and 30-day readmission rates.
resultsOverall compliance with the ERAS® protocol was 78.6% across all 50 patients. Mean length of stay was 6.3 ± 2.7 days, with significantly shorter stays in patients who achieved >80% compliance (24/50 patients, 5.2 ± 1.8 days) compared with those below this threshold (26/50, 7.6 ± 3.0 days; p=0.003). The overall complication rate was 24% (12/50), while major complications (Clavien-Dindo grade ≥ III) occurred in 8% (4/50). The 30-day readmission rate was 4% (2/50). Greater compliance was associated with fewer overall complications (4/24 (16.7%) vs. 11/26 (42.3%); p=0.038), although it did not significantly influence major complications or readmissions.
conclusionsThe implementation of the ERAS® protocol in colorectal cancer surgery is feasible in a resource-constrained setting, with acceptable compliance rates. Higher compliance was associated with shorter hospital stay and reduced overall complication rates. The protocol can be safely applied to patients undergoing colorectal cancer surgeries, potentially improving outcomes and resource utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.